LON:DEST Destiny Pharma (DEST) Insider Trading & Ownership GBX 52.10 -0.90 (-1.70%) (As of 03:58 AM ET) Add Compare Share Share Today's Range 52.10▼ 5450-Day Range 26.90▼ 5752-Week Range 25▼ 61.85Volume43,460 shsAverage Volume399,675 shsMarket Capitalization£49.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Insider TradesProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesOptions ChainProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesOptions Chain Destiny Pharma (LON:DEST) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.92%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£22,137.87Number OfInsiders Selling(Last 12 Months)0 Get DEST Insider Trade Alerts Want to know when executives and insiders are buying or selling Destiny Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DEST Insider Buying and Selling by Quarter Destiny Pharma Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails5/25/2023Nick RodgersInsiderBuy49,477GBX 31£15,337.872/27/2023Nick RodgersInsiderBuy20,000GBX 34£6,800 (Data available from 1/1/2013 forward) DEST Insider Trading Activity - Frequently Asked Questions Who is on Destiny Pharma's Insider Roster? The list of insiders at Destiny Pharma includes Nick Rodgers. Learn more on insiders at DEST. What percentage of Destiny Pharma stock is owned by insiders? 19.92% of Destiny Pharma stock is owned by insiders. Learn more on DEST's insider holdings. Which Destiny Pharma insiders have been buying company stock? The following insider purchased DEST shares in the last 24 months: Nick Rodgers (£273,717.87). How much insider buying is happening at Destiny Pharma? Insiders have purchased a total of 71,577 DEST shares in the last 24 months for a total of £273,717.87 bought. More Insider Trading Tools from MarketBeat Related Companies: SAR Insider Trading SBTX Insider Trading ORPH Insider Trading TRX Insider Trading POLB Insider Trading ETX Insider Trading OKYO Insider Trading OBD Insider Trading NSCI Insider Trading ONC Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Institutions and Insiders Are Gobbling Up Shares of HASIInsiders Are Buying These 2 Stocks3 Health Companies with Healthy Insider Buying and Market Support2 Cheap Stocks The Insiders Are Buying 3 Stocks to Buy After Heavy Insider Buying This page (LON:DEST) was last updated on 9/21/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Destiny Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.